Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Anterix (ATEX) EBITDA (2016 - 2025)

Historic EBITDA for Anterix (ATEX) over the last 13 years, with Q4 2025 value amounting to -$9.1 million.

  • Anterix's EBITDA fell 22885.38% to -$9.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $83.5 million, marking a year-over-year increase of 36403.66%. This contributed to the annual value of -$11.2 million for FY2025, which is 2029.61% down from last year.
  • According to the latest figures from Q4 2025, Anterix's EBITDA is -$9.1 million, which was down 22885.38% from $60.7 million recorded in Q3 2025.
  • In the past 5 years, Anterix's EBITDA registered a high of $60.7 million during Q3 2025, and its lowest value of -$15.0 million during Q2 2024.
  • Its 5-year average for EBITDA is -$613150.0, with a median of -$8.7 million in 2022.
  • Data for Anterix's EBITDA shows a peak YoY increase of 62569.66% (in 2024) and a maximum YoY decrease of 68123.06% (in 2024) over the last 5 years.
  • Quarter analysis of 5 years shows Anterix's EBITDA stood at -$12.4 million in 2021, then surged by 32.09% to -$8.4 million in 2022, then surged by 111.53% to $969000.0 in 2023, then soared by 625.7% to $7.0 million in 2024, then tumbled by 228.85% to -$9.1 million in 2025.
  • Its EBITDA was -$9.1 million in Q4 2025, compared to $60.7 million in Q3 2025 and $22.5 million in Q2 2025.